Episode #542 - From Marketing the Cure to Discovering It: Two Founders, Two Frontlines
Description
In this powerful ScaleUp Radio Shorts episode, Kevin Brent and Granger Forson contrast two founders tackling very different ends of the healthcare and life sciences spectrum:
- Michael Colling-Tuck, founder of Agency Medical Marketing, is on a mission to ensure life-changing innovations get adopted by clinicians and patients.
- Prasun Chakraborty, founder of Genevation, is developing personalised cancer vaccines using cutting-edge AI and immunotherapy.
One is solving the problem of visibility and market traction. The other is solving for scientific possibility and clinical impact. Yet both share a relentless sense of purpose and founder resilience.
What You'll Learn:
✅ The commercial vs scientific ends of the innovation lifecycle
✅ How founder motivation shapes business strategy
✅ Different approaches to funding, operations and visibility
✅ Why isolation, pressure and resilience are universal for founders
Standout Quotes:
"Only 5% of life-changing medical innovations succeed – not because they don't work, but because no one knows about them." – Michael
"I think like a patient so I can build for the patient." – Prasun
Key Takeaway:
Innovation dies without commercial traction, and commercial traction is meaningless without innovation. Founders must either build the bridge—or be the breakthrough.
United States
